Abacavir sulphate 300 mg
Product Description
Cipla Ltd
-
IN -
2015On CPHI since
Company types
Categories
Specifications
Cipla Ltd
-
IN
-
2015On CPHI since
Company types
More Products from Cipla Ltd (99)
-
Product Amoxicillin 200 mg + clavulanic acid 28.5 mg
Cipla Ltd offers wide range of formulation products which includes amoxicillin 200 mg + clavulanic acid 28.5 mg. Dosage form: dry syrup. Therapeutic area: antiinfectives. Packaging type: bottle. Contact us for more information. -
Product Amoxicillin 200 mg + clavulanic acid 5.7 mg/ml
Cipla Ltd offers wide range of formulation products which includes amoxicillin 200 mg + clavulanic acid 5.7 mg/ml. Dosage form: syrup. Therapeutic area: antiinfectives. Packaging type: bottle. Contact us for more information. -
Product Amoxicillin 200 mg/ml
Cipla Ltd offers wide range of formulation products which includes amoxicillin 200 mg/ml. Dosage form: rediuse. Therapeutic area: antiinfectives. Packaging type: bottle. Contact us for more information. -
Product 4-dimethylamino-2-methyl phenyl phosphine sodium 200mg + cyanocobalamine 50mcg/ml
Cipla Ltd offers wide range of veterinary products which includes 4-dimethylamino-2-methyl phenyl phosphine sodium 200mg + cyanocobalamine 50mcg/ml. Dosage form: injection. Contact us for more information. -
Product Abacavir sulfate
Cipla Ltd offers wide range of api which includes abacavir sulfate. It belongs to abacavir sulfate category. Contact us for more information. -
Product Abacavir sulphate 20 mg/ml
Cipla Ltd offers wide range of formulation products which includes abacavir sulphate 20 mg/ml. Dosage form: oral solution. Therapeutic area: hiv-aids. Packaging type: bottle. Contact us for more information. -
Product Abacavir sulphate 60 mg
Cipla Ltd offers wide range of formulation products which includes abacavir sulphate 60 mg. Dosage form: tablets. Therapeutic area: hiv-aids. Packaging type: container. Contact us for more information. -
Product Abacavir sulphate 60 mg + lamivudine 30 mg
Cipla Ltd offers wide range of formulation products which includes abacavir sulphate 60 mg + lamivudine 30 mg. Dosage form: tablets. Therapeutic area: hiv-aids. Packaging type: container. Contact us for more information. -
Product Abacavir sulphate 600 mg + lamivudine 300 mg
Cipla Ltd offers wide range of formulation products which includes abacavir sulphate 600 mg + lamivudine 300 mg. Dosage form: tablets. Therapeutic area: hiv-aids. Packaging type: container. Contact us for more information. -
Product Abamectin 3.7 mg + praziquantel 46.2 mg / gm
Cipla Ltd offers wide range of veterinary products which includes abamectin 3.7 mg + praziquantel 46.2 mg / gm. Dosage form: oral paste. Contact us for more information. -
Product Acarbose 100 mg
Cipla Ltd offers wide range of formulation products which includes acarbose 100 mg. Dosage form: tablets. Therapeutic area: diabetology. Packaging type: blister. Contact us for more information. -
Product Acarbose 25 mg
Cipla Ltd offers wide range of formulation products which includes acarbose 25 mg. Dosage form: tablets. Therapeutic area: diabetology. Packaging type: blister. Contact us for more information.
Cipla Ltd resources (1)
-
News Cipla and Kemwell to form joint venture targeting respiratory biosimilars market
The agreement is expected to accelerate Cipla’s global lung leadership agenda
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance